companydata.dkBIOMOTION PHARMA ApS: Financial statements 2020
CVR: 12928203
BIOMOTION PHARMA ApS (CVR 12928203) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -1,250 and a net result of DKK -1,250 compared with DKK -1,501 the year before. Equity amounted to DKK 1,250. The solvency ratio was 50%.
- Gross Profit
- -1,250 kr.
- Profit/Loss
- -1,250 kr.
- Equity
- 1,250 kr.
- Total Assets
- 2,500 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -1 t. | -1 t. | 1 t. | - |
| 2019 | - | -2 t. | -2 t. | 3 t. | - |
| 2018 | - | 5 t. | 5 t. | 4 t. | - |
| 2017 | - | - | 0 | -999 | - |
| 2016 | - | 0 | 0 | -999 | - |
How creditworthy is BIOMOTION PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of September 25, 2020, EY Godkendt Revisionspartnerselskab has been appointed auditor of BIOMOTION PHARMA ApS.
As of September 25, 2020, JUT NR. 2180 A/S has stepped down as auditor of BIOMOTION PHARMA ApS.
About BIOMOTION PHARMA ApS
BIOMOTION PHARMA ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 1989. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named HANDEL OG INVESTERING AF 1989 ApS and DANSK FARMASAN A/S. The management consists of Henrik Selchau Poulsen. The company is owned by Michael Rasmussen. In 2024, the company reported a gross profit of DKK -5,313 and a net result of DKK -6,460 compared with DKK -1,430 the year before. Equity amounted to DKK 3,310.